Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,166
Health Advocate for Children After Liver Transplant
for
Pediatric Liver Transplanted Recipients
Location: Pittsburgh PA, San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 0 - 18
Code: NCT07279350
Recruiting
Quality of End-of-Life Care for Children With Cancer
for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Pittsburgh PA, Cleveland OH, Charlottesville VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 18+
Code: NCT07412002
Recruiting
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
for
Homocystinuria
Location: Pittsburgh PA, Chevy Chase MD, Philadelphia PA,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 12 - 65
Code: NCT06247085
Phase 3, Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Pittsburgh PA, Ann Arbor MI, Cincinnati OH,
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Pittsburgh PA, Columbus OH, Ann Arbor MI, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
Minima Stent System Post- Approval Study (PAS)
for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Pittsburgh PA, Columbus OH, Charlottesville VA,
Sponsor: Renata Medical
Sex: All
Age: 0+
Code: NCT06828770
Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Pittsburgh PA, Washington D.C. DC, Burlington, Toronto,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Pittsburgh PA, Akron OH, Falls Church VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
for
Phenylketonuria (PKU)
Location: Pittsburgh PA, Gainesville FL, Tampa FL, Dallas TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 4+
Code: NCT06628128
Phase 3, Recruiting
Childhood Cancer Survivor Study
for
Cancer
Location: Pittsburgh PA, Columbus OH, Buffalo NY,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01120353
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia